Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Test shows new Liberian Ebola case similar to earlier virus

Published 10/07/2015, 12:20
Test shows new Liberian Ebola case similar to earlier virus

DAKAR/GENEVA (Reuters) - Tests on the Ebola virus that claimed Liberia's first victim since it was declared Ebola-free in May showed it was closely related to an earlier Liberian strain, the World Health Organization and a health official said on Friday.

The findings suggest the disease was never entirely eliminated from the West African country.

"It indicates that the virus is closely related to one that was circulating in Liberia in that particular area," WHO spokesman Tarik Jasarevic said, confirming initial results of the genetic tests obtained by Reuters.

"So it's either (from) a survivor or non-identified transmission in the community," he added.

Liberia's first Ebola case in nearly two months was reported on June 30 when the body of a 17-year-old boy, Abraham Memaigar, tested positive for the virus in Margibi County.

The case has baffled officials since Memaigar lived far from the hotspots of the epidemic on the borders with Guinea and Sierra Leone, and was not known to have been in contact with any travellers.

Ebola is thought to be able to survive no more than 21 days in most body fluids, such as blood and vomit, but is known to persist in semen and in some soft tissues, such as the eye, for months after recovery.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.